CD82 and breast cancer: Evaluating KAI-1 expression may help to predict the breast cancer patients with metastatic propensity, high aggressiveness and a poor prognosis as LNM is the primary conduit for distant metastasis in BC and associated with aggressive phenotype and poor prognosis.